Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 24, 2012
Telestroke network business model strategies
Christopher V Fanale, Bart M Demaerschalk
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
February 10, 2016
A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center
Alessandro Orlando, Jeffrey C Wagner, Christopher V Fanale, et al.
The Neurohospitalist
|
April 13, 2017
How a CT-Direct Protocol at an American Comprehensive Stroke Center Led to Door-to-Needle Times Less Than 30 Minutes
Lisa M Caputo, Judd Jensen, Michelle Whaley, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
July 24, 2015
Age ≥80 Years Is Not a Contraindication for Intra-Arterial Therapy after Ischemic Stroke
Jan Leonard, Donald Frei, Kristin Salottolo, et al.
Annals of Neurology
|
June 9, 2016
Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke
Andrew D Barreto, Christopher V Fanale, Andrei V Alexandrov, et al.
Stroke
|
November 5, 2016
Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Lawrence R Wechsler, Bart M Demaerschalk, Lee H Schwamm, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
July 24, 2012
Telestroke network business model strategies
Christopher V Fanale, Bart M Demaerschalk
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
February 10, 2016
A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center
Alessandro Orlando, Jeffrey C Wagner, Christopher V Fanale, et al.
The Neurohospitalist
|
April 13, 2017
How a CT-Direct Protocol at an American Comprehensive Stroke Center Led to Door-to-Needle Times Less Than 30 Minutes
Lisa M Caputo, Judd Jensen, Michelle Whaley, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
July 24, 2015
Age ≥80 Years Is Not a Contraindication for Intra-Arterial Therapy after Ischemic Stroke
Jan Leonard, Donald Frei, Kristin Salottolo, et al.
Annals of Neurology
|
June 9, 2016
Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke
Andrew D Barreto, Christopher V Fanale, Andrei V Alexandrov, et al.
Stroke
|
November 5, 2016
Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Lawrence R Wechsler, Bart M Demaerschalk, Lee H Schwamm, et al.
Page
of 1